Last update Nov. 8, 2024
Compatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Пирантела Эмбонат is Pyrantel Embonate in Cyrillic.
Is written in other languages:Пирантела Эмбонат is also known as
Main tradenames from several countries containing Пирантела Эмбонат in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | baja / poor | % |
Molecular weight | 595 | daltons |
Tmax | 1 - 3 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Pyrantel is a pyrimidine-derived anthelmintic agent for the oral treatment of various parasitic infections, including ascariasis, hookworm infections, enterobiasis (pinworm infection), trichostrongyliasis and trichinellosis. Oral administration in single or repeated doses after two weeks. Some helminths require treatments of 3 to 4 days.
At the date of the last update we found no published data on its excretion in breast milk.
Given its low gastrointestinal absorption, reaching very low plasma concentrations, < 0.04 micrograms/mL (Fasanmade 1994), which hinders both the passage into the mother's plasma, and therefore into breast milk, and into the infant's plasma from ingested breast milk, the short period of treatment required and the benign nature of the possible side effects, expert authors consider it acceptable during breastfeeding. (LactMed)
Authorized in infants from 6 months of age.
WHO list of essential medicines: compatible with breastfeeding. (WHO-UNICEF 2002)